Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced synthesis route for Tenofovir intermediate CN103408547B. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supply chain solutions.
Patent CN105461538A details a safer Grignard route for m-trifluoromethyl acetophenone. This method offers significant cost reduction and supply chain reliability for agrochemical manufacturing.
Patent CN101830820B reveals a novel ethylene glycol-water dispersion method for DTTA, offering high yield and reduced solvent waste for quinacridone pigment manufacturing.
Patent CN113511994B details a high-purity levetiracetam synthesis using chiral BINOL-derived phosphoric acid, offering superior enantioselectivity and simplified one-pot processing for pharmaceutical manufacturers.
Patent CN114436876B reveals a continuous ether-solvent process for high-purity dye intermediates, offering significant cost and supply chain advantages.
Patent CN121135789A reveals a novel supramolecular catalytic route for chiral Ugi amine. Achieve 99% ee and 99% yield with scalable, cost-effective manufacturing for global supply chains.
Patent CN101674835A reveals a streamlined synthesis for Galantamine intermediate C2, offering significant cost reduction and improved purity for API manufacturing supply chains.
Patent CN111187160A details a green aqueous synthesis of esters using carboxylic acids and enones, offering significant cost reduction and high purity for pharmaceutical intermediates manufacturing.
Discover a scalable synthesis route for chiral binaphthalene dicarboxylic acid via patent CN101781197A. Achieve >99% optical purity and significant cost reduction in pharma intermediate manufacturing.
Novel nitrone-based route for branched polyhydroxypyrrolidine derivatives offers high stereoselectivity and scalable manufacturing for imino sugar intermediates.
Novel esterification and deprotection technology for candesartan cilexetil intermediates. High yield, mild conditions, suitable for large-scale pharmaceutical manufacturing.
Patent CN102388017B details an anhydrous synthesis route for azelaic acid derivatives, offering improved purity and yield for cosmetic and pharmaceutical intermediate manufacturing.
Novel low-valent titanium method for HIV protease inhibitor intermediates offering cost-effective scale-up and high purity for global pharma supply chains.
Discover the novel three-step synthesis of alpha,alpha-fluorochloroarylmethyl phosphonates via Pudovik addition and electrophilic fluorination for PTPs inhibitor development.
Patent CN1033521A reveals a safer route to Famotidine intermediates using bicyclic amidine salts, eliminating toxic hydrogen sulfide and improving supply chain reliability for pharmaceutical manufacturers.
Novel metal-catalyzed process for 1-beta-methyl carbapenem intermediates. High yield, mild conditions, scalable production for global supply chains.
Patent CN1486316A details a one-pot synthesis for carbapenems. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106938983B reveals nickel-catalyzed olefin synthesis. Achieve cost reduction in fine chemical manufacturing with high-purity intermediates and scalable processes.
Patent CN1084166A reveals novel benzothiazolyl methoxy phenyl-acetic acid synthesis. Enables cost reduction in API manufacturing for leukotriene inhibitors.
Patent CN1227250C reveals a safer, scalable route for CDK inhibitor intermediates, eliminating hazardous diazo compounds and chromatography for cost-effective manufacturing.